Package 63539-501-30

Brand: xeljanz xr

Generic: tofacitinib
NDC Package

Package Facts

Identity

Package NDC 63539-501-30
Digits Only 6353950130
Product NDC 63539-501
Product ID 63539-501_c422393a-1e5c-46d2-81df-3d05818bf50e
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30)

Marketing

Marketing Status
Marketed Since 2016-03-07
Brand xeljanz xr
Generic tofacitinib
Sample Package No

Linked Drug Pages (1)

XELJANZ, XELJANZ XR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c422393a-1e5c-46d2-81df-3d05818bf50e", "openfda": {"unii": ["O1FF4DIV0D"], "rxcui": ["1357541", "1357547", "1741046", "1741049", "2048566", "2048568", "2273113", "2273115", "2478433", "2478437"], "spl_set_id": ["68e3d6b2-7838-4d2d-a417-09d919b43e13"], "manufacturer_name": ["U.S. Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14)", "package_ndc": "63539-501-14", "marketing_start_date": "20160307"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30)", "package_ndc": "63539-501-30", "marketing_start_date": "20160307"}], "brand_name": "XELJANZ XR", "product_id": "63539-501_c422393a-1e5c-46d2-81df-3d05818bf50e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Janus Kinase Inhibitor [EPC]", "Janus Kinase Inhibitors [MoA]"], "product_ndc": "63539-501", "generic_name": "tofacitinib", "labeler_name": "U.S. Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "XELJANZ", "brand_name_suffix": "XR", "active_ingredients": [{"name": "TOFACITINIB CITRATE", "strength": "11 mg/1"}], "application_number": "NDA208246", "marketing_category": "NDA", "marketing_start_date": "20160307", "listing_expiration_date": "20271231"}